Protection of chickens against avian influenza with non-replicating adenovirus-vectored vaccine.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 60 citations in OpenAlex.

1. Viral vector-based influenza vaccines.Human vaccines & immunotherapeutics · 2016
   Pooled it
2. Recombinant human adenovirus type 5-vectored vaccine expressing avian reovirus σC protein protects against prevalent genotype I avian reovirus in chickens.Poultry science · 2026
   Article
3. Novel Recombinant Newcastle Disease Virus-BasedVaccines · 2021
   Article
4. Replicating Single-Cycle Adenovirus Vectors Generate Amplified Influenza Vaccine Responses.Journal of virology · 2017
   Article
5. Prevalence and control of H7 avian influenza viruses in birds and humans.Epidemiology and infection · 2014
   Review
6. Advances and future challenges in recombinant adenoviral vectored H5N1 influenza vaccines.Viruses · 2012
   Review
7. Development of adenoviral vector-based mucosal vaccine against influenza.Journal of molecular medicine (Berlin, Germany) · 2011
   Review
8. Production of adenovirus vectors and their use as a delivery system for influenza vaccines.Expert opinion on biological therapy · 2010
   Review
9. Non-replicating adenovirus vectors expressing avian influenza virus hemagglutinin and nucleocapsid proteins induce chicken specific effector, memory and effector memory CD8(+) T lymphocytes.Virology · 2010
   Article
10. Development of avian influenza virus H5 DNA vaccine and MDP-1 gene of Mycobacterium bovis as genetic adjuvant.Genetic vaccines and therapy · 2010
    Article
11. Induction of a Protective Heterosubtypic Immune Response Against the Influenza Virus by using Recombinant Adenoviral Vectors Expressing Hemagglutinin of the Influenza H5 Virus.Acta naturae · 2010
    Article
12. Avian influenza vaccination in chickens and pigs with replication-competent adenovirus-free human recombinant adenovirus 5.Avian diseases · 2010
    Article
13. Improved efficacy of a gene optimised adenovirus-based vaccine for venezuelan equine encephalitis virus.Virology journal · 2009
    Article
14. A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults.Vaccine · 2009
    Article
15. Adenovirus as a carrier for the development of influenza virus-free avian influenza vaccines.Expert review of vaccines · 2009
    Review
16. A gene-based avian influenza vaccine in poultry.Poultry science · 2009
    Article
17. The prevention and control of avian influenza: the avian influenza coordinated agriculture project.Poultry science · 2009
    Article
18. Induction of mucosal immunity in the avian Harderian gland with a replication-deficient Ad5 vector expressing avian influenza H5 hemagglutinin.Developmental and comparative immunology · 2009
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

5 authors at 2 institutions in 1 country.

Funding

Abstract

Indexed as